Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

7965.      Abravaya K, Huff J, Marshall R, Merchant B, Mullen C, Schneider G, Robinson J. Molecular beacons as diagnostic tools: technology and applications. Clin Chem Lab Med. 2003 Apr;41(4):468-74. 

7966.      Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology. 2003 May;37(5):972-4. Review.

7967.      Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003 Jun;52(6):879-85.

7968.      Anzola M, Cuevas N, Lopez-Martinez M, Saiz A, Burgos JJ, de Pancorbo MM. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett. 2003 Apr 25;193(2):199-205.

7969.      Arndt T, Kuhn D, Herbst H, Linnemann M, Nikolaidis N. Increased carbohydrate-deficient transferrin of unknown etiology in a 15-year-old male patient with autoimmune hepatitis type 1. Clin Chem. 2003 Jun;49(6 Pt 1):1025-6.

7970.      Auroux J, Lamarque D, Roudot-Thoraval F, Deforges L, Chaumette MT, Richardet JP, Delchier JC. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci. 2003 Jun;48(6):1118-23.

7971.      Ballot E, Bruneel A, Labas V, Johanet C. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin Chem. 2003 Apr;49(4):634-43.

7972.      Berg T, Pascu M, Moller B. Prediction of spontaneous viral clearance in acute hepatitis C by viral load measurements. Hepatology. 2003 Jun;37(6):1495-6; author reply 1496.

7973.      Bolondi L. Screening tests for hepatocellular carcinoma. Hepatology. 2003 Jun;37(6):1493; author reply 1493.

7974.      Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, Muller MJ. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr. 2003 May;77(5):1269-77.

7975.      Brunetti G, Delmastro M, Nava S, Pignatti P, Bossi A, Gatti M, Furione M. Detection of HCV-RNA in bronchoalveolar lavage from a woman with pulmonary fibrosis. Respir Med. 2003 Jun;97(6):736-8.

7976.      Burchell AN, Calzavara LM, Myers T, Schlossberg J, Millson M, Escobar M, Wallace E, Major C. Voluntary HIV testing among inmates: sociodemographic, behavioral risk, and attitudinal correlates. J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):534-41.

7977.      Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study. Transplantation. 2003 Apr 15;75(7):977-82.

7978.      Cengiz C, Akarca US, Goker E, Yuce G. Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters. Dig Dis Sci. 2003 May;48(5):865-9.

7979.      Chan MT, Gin T, Chui AK, Lau WY. Pitfalls of indocyanine green dye elimination to assess graft function during liver transplantation. Anesth Analg. 2003 Jun;96(6):1839-40; author reply 1840-1.

7980.      Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, Guguen-Guillouzo C. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem. 2003 May 16;278(20):18256-64. Epub 2003 Feb 20.

7981.      Gehrke SG, Riedel HD, Herrmann T, Hadaschik B, Bents K, Veltkamp C, Stremmel W. UbcH5A, a member of human E2 ubiquitin-conjugating enzymes, is closely related to SFT, a stimulator of iron transport, and is up-regulated in hereditary hemochromatosis. Blood. 2003 Apr 15;101(8):3288-93. Epub 2002 Dec 12.

7982.      Gelatti U, Donato F, Tagger A, Fantoni C, Portolani N, Ribero ML, Martelli C, Trevisi P, Covolo L, Simonati C, Nardi G; Brescia HCC Study. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol. 2003 Apr;98(4):907-14.

7983.      Golia P, Talal A. Editorial comment: diagnosis of acute HIV infection in hepatitis C treatment nonresponders--is extra vigilance required? AIDS Read. 2003 Jun;13(6):288-90.

7984.      Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis. 2003 Apr;30(4):340-4.

7985.      Hezode C, Lonjon I, Roudot-Thoraval F, Pawlotsky JM, Zafrani ES, Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther. 2003 Apr15;17(8):1031-7.

7986.      Ho SK, Yam WC, Leung ET, Wong LP, Leung JK, Lai KN, Chan TM. Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol. 2003 May;52(Pt 5):397-402.

7987.      Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer. 2003 Apr 15;97(8):1929-40.

7988.      James C, Trouette H, Marit G, Cony-Makhoul P, Mahon FX. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia. 2003 May;17(5):978-9.

7989.      Jeong SY, Kim KJ, Kim DJ, Oh SW, Choi EY. Sandwich ELISA for measurement of cytosolic aspartate aminotransferase in sera from patients with liver diseases. Clin Chem. 2003 May;49(5):826-9.

7990.      Kono Y, Hayashida K, Tanaka H, Ishibashi H, Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J Med Virol. 2003 May;70(1):42-8.

7991.      Lohr HF, Pingel S, Weyer S, Fritz T, Galle PR. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand J Immunol. 2003 Apr;57(4):384-90.

7992.      Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology. 2003 May;37(5):1114-21.

7993.      McKeown C, Thaker U, Cubitt WD, Novelli V. Retrospective screening for hepatitis C in a tertiary paediatric referral centre. Commun Dis Public Health. 2003 Apr;6(1):40-3.

7994.      Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology. 2003 Jun;37(6):1309-19. Review.

7995.      Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxi A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M.  Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol. 2003 Apr;162(4):1293-303.

7996.      Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, Healy M. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol. 2003 Apr;41(4):1558-64.

7997.      Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Curr Pharm Biotechnol. 2003 Jun;4(3):195-209. Review.

7998.      Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24;361(9371):1767-72.

7999.      Raghuraman S, Subramaniam T, Daniel D, Sridharan G, Abraham P. Occurrence of false positives during testing for antibodies to hepatitis C virus among volunteer blood donors in India. J Clin Microbiol. 2003 Apr;41(4):1788-90.

8000.      Riley NE, Li J, McPhaul LW, Bardag-Gorce F, Lue YH, French SW. Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol. 2003 Apr;74(2):168-72.

8001.      Sadeyen JR, Tourne S, Shkreli M, Sizaret PY, Coursaget P. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. Virology. 2003 Apr 25;309(1):32-40.

8002.      Serra JJ, Monte GU, Mello ES, Coral GP, Avila LF, Parga JR, Ramires JA, Rochitte CE. Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation. 2003 May 27;107(20):e188-9.

8003.      Soresi M, Bonfissuto G, Magliarisi C, Riili A, Terranova A, Di Giovanni G, Bascone F, Carroccio A, Tripi S, Montalto G. Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin Radiol. 2003 May;58(5):372-7.

8004.      Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T.  Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003 May;37(5):1220-1; author reply 1221.

8005.      Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology. 2003 May;37(5):1189-98.

8006.      Zanetti AR, Romano L, Brunetto M, Colombo M, Bellati G, Tackney C. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol. 2003 May;70(1):27-30.


8007.      Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS. Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol. 2003 May;77(10):6055-61.

8008.      Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology. 2003 Apr;37(4):924-30.

8009.      Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP; Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003 Jun;43(6):696-704.

8010.      Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol. 2003 Apr;77(8):4781-93.

8011.      Ogata N, Ichida T, Aoyagi Y, Kitajima I. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity. Rinsho Byori. 2003 Apr;51(4):313-9.

8012.      Poljak M, Seme K, Marin IJ, Babic DZ, Matcic M, Meglic J. Frequency of the 32-base pair deletion in the chemokine receptor CCR5 gene is not increased in hepatitis C patients. Gastroenterology. 2003 May;124(5):1558-60; author reply 1560-1.

8013.      Ruhl CE, Everhart JE.  Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology. 2003 Jun;124(7):1821-9.

8014.      Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology. 2003 May;37(5):1180-8.


8015. Soroosh P, Shokri F, Azizi M, Jeddi-Tehrani M. Analysis of T-cell receptor beta chain variable gene segment usage in healthy dult responders and nonresponders to recombinant hepatitis B vaccine. cand J Immunol. 2003 May;57(5):423-31.